Latest Cancer News

Votrient® plus Taxol® Promising in Relapsed and Refractory Bladder Cancer (03-30-2015)
The treatment combination of Votrient® (pazopanib) plus Taxol® (paclitaxel) appears active against bladder cancer that has not responded to or come back after previous therapy. These findings were presented... Continue Reading

Cytosponge Offers Minimally Invasive Screening Option for Barrett’s Esophagus (03-26-2015)
Screening for Barrett’s esophagus with a new device called a Cytosponge is accurate compared to endoscopy but less expensive and easier on patients. These findings were reported in the journal PLoS Medicine. Barrett’s... Continue Reading

Pacritinib May Be Effective against Myelofibrosis without Risk of Myelosuppression (03-25-2015)
The investigational agent pacritinib appears active against myelofibrosis without the risk of myelosuppression, a common side effect of many drugs used to treat myelofibrosis and other myeloproliferative... Continue Reading

More Cancer News

Events

Tower Oncology’s Cancer Support Network Brings New Services to West Side
Organizations partner to offer full range of cancer support and education to meet a growing need. Read more…


Tower Hematology Oncology Medical Group Named Fight Back Chair For American Cancer Society’s Relay for Life Event in Beverly Hills
Cancer treatment center seeks volunteers, donations for April 30 cancer support fundraiser
Read more…

Tower News

Tower Hematology Oncology Medical Group has been awarded a three-year term of accreditation in computed tomography (CT) and positron emission tomography (PET) as the result of a recent review by the American College of Radiology (ACR). CT scanning — sometimes called CAT scanning — is a noninvasive medical test that helps physicians diagnose and tailor treatments for various medical conditions. Learn more…

Locations

Tower Hematology Oncology Medical Group
9090 Wilshire Boulevard
Suite 200
Beverly Hills, CA 90211
Phone: (310) 888-8680
Click here for map